Happy Thursday.
In today’s issue:
Angel Deals of the Week | 264 Deals, 127 Networks
First time featured this week: Investors Circle and Women on the Cap Table
Bookmarks I think you’ll enjoy
The best nugget from my conversation with enterprise sales pro Rob Balena, former Head of Sales at TeamSense
🔥 Angel Deals of the Week
Angel funding rounds announced in recent weeks, compiled from public sources or via direct announcement. These deals represent the elite few that survived an angel network’s vetting process. Note: I have not personally analyzed these companies and am sharing for informational purposes only.
📊 Angel Network Investment Tracker: 264 Deals, 127 Networks.
🔓 The Exclusive: 19 Actively Raising Deals Shared to Date
Sameric Bio | Translating academic biology into real-world medicine
Participating Groups: Springboard Health Angels
Sameric Bio is developing protein-based medicines by licensing academic research and advancing it into clinical trials, and says it holds exclusive licenses to programs in fibrosis (tissue scarring) and cancer. Springboard Health Angels recently announced an investment in the company.
Lorenzo Corsini | Vienna, Austria | October 2026 | Source
it’s electric | Curbside EV charging for cities
Participating Groups: E8 Angels, Investors Circle
It’s electric is developing curbside EV chargers powered by spare electricity from adjacent buildings, and says it has won city contracts in Boston, Los Angeles and New York City. E8 Angels and Investors Circle recently announced investments in the company.
Nathan L. King | Brooklyn, NY | October 2026 | Source
AptaDir Therapeutics | RNA drugs for genetic disorders
Participating Groups: Italian Angels for Biotech, Club degli Investitori
AptaDir is developing RNA drugs for Fragile X syndrome, a genetic condition that causes intellectual disability. Italian Angels for Biotech and Club degli Investitori recently announced an investment in the company as part of its $45 million USD (€40 million) seed round.
Giovanni Amabile | $45M Seed | Milan, Italy | September 2026 | Source
Narratize | AI product development for manufacturers
Participating Group: Women on the Cap Table
Narratize is developing AI software that helps manufacturers organize product knowledge to develop new products. Women on the Cap Table recently announced an investment in the company as part of a round led by Astia and Silicon Road Ventures.
Katie Trauth Taylor | Cincinnati, OH | September 2026 | Source 1, Source 2
NexPlasmaGen | Cold plasma breast cancer treatment
Participating Group: SWAN Impact Network
NexPlasmaGen is developing noninvasive cold plasma technology (room-temperature ionized gas) to kill leftover cancer cells after breast tumor removal, with funding support from Canada’s National Research Council. SWAN Impact Network recently announced a follow-on investment in the company.
Valérie Léveillé | Montreal, Canada | September 2026 | Source
📣 Have an Angel Deal to Announce?
You just read who raised. The Exclusive tells you who's still raising.
When an angel group backs a company, I contact the founder to ask if the round is open. If it is, members get the deck, my memo, and an intro to the founder.
They also get deals that come to me directly and never appear in this newsletter.
$50/month for the first 25 members. 10 seats left. Full refund within 30 days. Accredited investors only.
🔖 Bookmarks
🚩 Diligence the Pitch Competition: Founders, vet the organizers. Founder Joanna Shu tells the tale of a “$100K” pitch competition that turned into weeks of wasted time and zero dollars.
🔔 Anthropic Files to Go Public: Anthropic filed its S-1 on Monday and plans to list on the Nasdaq under the ticker “ANT.”
📖 Word of the Year: Dictionary.com named “maxxing” its 2026 Word of the Year, with tokenmaxxing (using as much AI at work as possible) making the list of spinoffs.
🥇 The Nugget: My Top Takeaway from A Conversation with Rob Balena
Big logo? Ask for the big story 🔍
A Fortune 500 logo on a slide could represent a real beachhead customer.
Or it could represent a favor and a one-time unpaid pilot.
How to tell the difference? Get the details. Rob described how, at Cloudera, he turned a tiny foothold at Dell into a full account takeover by showing up at Dell’s office every Tuesday and Thursday for three years. That’s a long-term strategy.
Many founders attempt to “skip the process” by throwing out a big one-time discount or pulling strings with an executive. While that approach can provide some short-term benefit, it can also burn the relationship and fizzle out quickly.
From Rob: “You’re going to do that with that customer exactly once. And you’re mortgaging your future with that customer.”
Takeaway: Pick the biggest logo on the deck and say, “Tell me the story.” Specifics = promising. Generalities = red flag 🚩.
Want more? Check out my full conversation with Rob 👇
Listen now on Apple Podcasts, Spotify, YouTube, and more.
In Partnership with Wispr Flow
Stop typing AI prompts. Start talking.
You think 4x faster than you type. So why are you typing prompts? Wispr Flow turns your voice into ready-to-paste text inside any AI tool. Speak naturally, tangents and all, and Flow cleans it up. Available on Mac, Windows, iPhone, and Android.
Until Next Week 👋
Thanks for reading - have a great week.
-Andrew
If you’re finding this newsletter valuable, share it with a friend, and consider subscribing if you haven’t already. You can also find me on LinkedIn and X.
Advertise with The Diligent Observer.
